CALDESENE DIAPER RASH TREATMENT SAFETY/EFFICACY STUDIES DISCUSSED
This article was originally published in The Tan Sheet
Executive Summary
CALDESENE DIAPER RASH TREATMENT SAFETY/EFFICACY STUDIES DISCUSSED at a Jan. 24 meeting between FDA officials and representatives from Ciba Consumer, which acquired the Caldesene line and other OTCs from Fisons in late 1992. According to an agency memorandum of the meeting, Ciba Consumer requested the session to "determine the overall status and possible need for testing of Caldesene" products containing calcium undecylenate to support claims for diaper rash.